VGV Q3 Newsletter 2021
A quarterly update on VGV portfolio companies, partners, and industry trends.
Portfolio Company Highlights
S4 Medical Kicking-Off Clinical Studies
A congratulation is in order for VGV portfolio company, S4 Medical. Recently, S4 Medical announced its first patient to be enrolled and treated in the Easy AF IDE Study at The Ohio State University Ross Heart Medical Center.
S4 is focused on developing solutions for safer and more effective catheter ablation treatment for atrial fibrillation. The clinical resolution is a catheter-based device designed to displace the esophagus away from the source of ablation energy during ablation of AF and to minimize the risk of esophageal injury. It is not yet approved for commercial use.
Follow S4 Medical on LinkedIn for more company updates
Virtual Avatars, Home Safety Take Top Prizes at YBI Shark Tank Event
The Youngstown Business Incubator held its second Shark Tank event, their biggest fundraiser of the year. They had businesses and entrepreneurs pitch their ideas to a live audience of more than 500 people in order to gain exposure.
This year's winners are Devyn Bellamy with GERAS Home Solutions for “audience choice” and Jame van Doren with Neverending for “sharks’ choice.”
YSU Exceeds Campaign Goals by $26 million
Youngstown State University's largest fundraising campaign in the school's history has exceeded its goal of $100 million — totaling $126,187,126! During the quarterly Board of Trustees meeting Paul McFadden, the YSU Foundation’s president, said the university soon plans to release several TV commercials detailing how the funds will impact YSU.
Is Sequoia's Fund Restructuring Really a Game-Changer for VC?
"The VC industry appeared to reach something of a watershed moment when Sequoia fundamentally restructured its vast portfolio into a single master fund.
With the announcement, Sequoia declared that as far as its business is concerned, the venture industry's standard 10-year fund cycle is "obsolete." It's an innovative move for sure, and one that is perhaps overdue. But while it may help solve some problems, it could also be creating new ones."